A.R.T. Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

A.R.T. Advisors’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-31,174	Closed	-$30K	–	1118
2019 Q4	$30K	Buy	+31,174	New	+$34.2K	﹤0.01%	1271
2019 Q2	–	Sell	-21,910	Closed	-$41K	–	1709
2019 Q1	$41K	Buy	+21,910	New	+$32.1K	﹤0.01%	1227
2017 Q4	–	Sell	-181,220	Closed	-$241K	–	1747
2017 Q3	$241K	Buy	181,220 +90,500	+100%	+$112K	0.01%	1081
2017 Q2	$142K	Buy	+90,720	New	+$175K	0.01%	1215
2016 Q4	–	Sell	-19,400	Closed	-$30K	–	1432
2016 Q3	$30K	Sell	19,400 -139,107	-88%	-$214K	0.01%	611
2016 Q2	$210K	Buy	+158,507	New	+$741K	0.01%	1092
2015 Q3	–	Sell	-180,925	Closed	-$1.98M	–	1667
2015 Q2	$1.98M	Buy	+180,925	New	+$2.32M	0.07%	451
2014 Q4	–	Sell	-20,877	Closed	-$280K	–	1719
2014 Q3	$280K	Buy	+20,877	New	+$249K	0.01%	966
2014 Q1	–	Sell	-43,866	Closed	-$605K	–	1611
2013 Q4	$605K	Buy	+43,866	New	+$620K	0.03%	697
2013 Q3	–	Sell	-423,079	Closed	-$6.85M	–	1547
2013 Q2	$6.85M	Buy	+423,079	New	+$13.1M	0.22%	123

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

A.R.T. Advisors's INFI Position: Q1 2020 in Review

A.R.T. Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2020, closing a stake of 31,174 shares — an estimated $30K sold.

A.R.T. Advisors first reported a position in INFI in Q2 2013 and held it in 10 quarters. The position peaked at $6.85M in Q2 2013. 48 funds tracked by Wall St. Rank hold INFI as of Q1 2020.

A.R.T. Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 31,174 Infinity Pharmaceuticals, Inc. shares in Q1 2020, an estimated $30K.
A.R.T. Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 10 quarters.
A.R.T. Advisors's Infinity Pharmaceuticals, Inc. position peaked at $6.85M in Q2 2013.
48 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.